Summary:

Advances in science and technology have contributed towards a growing arsenal of methodologies for studying molecules and their interactions in systems of pharmaceutical interest. The screening process- preformulation, leverages available methodologies to support a wide array of activities at various stages of a typical industrial R&D program. To a relative newcomer in an industrial setting, the business approach to the screening process may appear complex. This talk will familiarize the audience with different approaches to industrial preformulation programs, summarize the evolution of the field, current thinking and potential areas of growth in the next few years.

Topics that will be covered:

- What is preformulation?
- How do preformulation activities fit into today's industrial R&D set up?
- What do young scientists need to know when they enter or interface with a preformulation group?
- Dr. Phadnis' own experiences highlighted with references to 1-3 case studies of relevance.

Dr. Phadnis is part of the Pharmaceutical Sciences team at Neurogen Corp. Prior to this, she worked at GlaxoSmithKline and Schering Plough, where she contributed to the rapid development of a variety of dosage forms such as fast acting tablets, quick disintegrating tablets, lozenges, chewing gum, soft chews and topical semisolids. Her efforts resulted in successful product launches for brands such as Panadol, TUMS, NiQuitin, Claritin and Dr. Scholl's. In her current role, Dr. Phadnis builds on previous professional experience in the areas of preformulation, formulation development, leadership, project management and problem solving so that company objectives are met.

Dr. Phadnis is a proud recipient of GSK Impact Awards, a USP Fellowship, ISWOP scholarship and AAPS' 1995 Proctor & Gamble Award. In 2005-2006, Dr. Phadnis served as the chair of AAPS' Preformulation Focus Group. Novel applications of techniques and novel techniques for application in the area of preformulation-formulation research continue to fuel her professional interest.

Dr. Phadnis received her Ph.D. from the University of Minnesota, M. Pharm from Gujarat University and B. Pharm from University of Delhi.

General Information:

-Webinar requires Windows Media Player and speakers. Broadband Internet connection is preferred.
-For group viewing in a conference room or classroom, we recommend external speakers and an LCD projector.
-The audio for the lecture will be heard via your computer's speaker system. No telephone dial-in is required.
-When registering, be sure to run the system test and read the instructions.
-You will receive a confirmation email with access passwords and link to presenter's PDF files if you register at least 24 hours prior to event.

Note: from the system check page, you may elect to run a sample webcast to be sure you can receive the webcast. If you wish to do so, be sure to click on the Sample Audio Webcast link on that page.